Anders Olof Adolf Ekblom
Net worth: 90 272 $ as of 2026-07-30
Net worth: 90 272 $ as of 2026-07-30
Dr. Anders Olof Adolf Ekblom is a Chairman at Elypta AB, an Independent Director at Alligator Bioscience AB, an Independent Non-Executive Director at Mereo BioPharma Group Plc and an Associate Professor at Karolinska Institutet. He is on the Board of Directors at LEO Pharma A/S, Alligator Bioscience AB, Mereo BioPharma Group Plc, AnaMar AB, Modul 1 Data AB, Forska Sverige, NxtScience AB and Vetenskapsrådet. Dr. Ekblom was previously employed as a Chairman by TFS Trial Form Support AB, an Independent Director by Infant Bacterial Therapeutics AB, a Chairman by Karolinska University Hospital, a Chief Executive Officer by AstraZeneca AB, and a Chief Executive Officer & Director by AstraZeneca Plc. He also served on the board at RSPR Pharma AB, Medivir AB, Viscogel AB, SwedenBIO Service AB, Albireo AB, Albireo Ltd., Palette Life Sciences AB and Sällheten Invest AB. He received his doctorate degree from Karolinska Institutet.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FLERIE AB 0.04% | 2025-12-30 | 30,831 ( 0.04% ) | 66 251 $ | 2026-07-30 |
| 2026-03-25 | 189,700 ( 0.02% ) | 13 013 $ | 2026-07-30 | |
XSPRAY PHARMA AB 0.01% | 2025-12-30 | 6,221 ( 0.01% ) | 11 007 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Director/Board Member | 2015-06-30 |
| XSPRAY PHARMA AB | Chairman | 2022-05-18 |
| FLERIE INVEST AB | Director/Board Member | 2022-12-31 |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Director/Board Member | 2023-12-31 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Director/Board Member | - |
XSpray Pharma Futurum AB | Corporate Officer/Principal | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Engages in research and development, develops & sells type 2 diabetes | Chairman | 2021-12-31 |
NxtScience AB | Director/Board Member | - |
Forska Sverige
Forska Sverige Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Director/Board Member | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 29 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Modul 1 Data AB
Modul 1 Data AB Information Technology ServicesTechnology Services Provides IT consulting and management services | Technology Services |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alligator Bioscience AB
Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services Provides clinical trial and contract research services | Commercial Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
Xspray Pharma AB
Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
Viscogel AB | |
RSPR Pharma AB
RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Vetenskapsrådet | |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Develops products that improve the quality of life for patients | Health Technology |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Finance |
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Engages in research and development, develops & sells type 2 diabetes | Health Technology |
Forska Sverige
Forska Sverige Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
NxtScience AB | |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Sällheten Invest AB | |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Commercial Services |
XSpray Pharma Futurum AB |
Select your edition
All financial news and data tailored to specific country editions